P-202 Demographics and clinical characteristics of metastatic colorectal cancer patients treated with a biosimilar to bevacizumab von Rhodes, W., Accortt, N., DeClue, R., Jin, R., Sandschafer, D., Wertz, D., Patel, K.

Volltext

MT17 Assessment of Device Failures and Medication Errors with the Pegfilgrastim on-Body Injector in the US and EU von Sandschafer, D, Choi, A, Lewis, S, Upchurch, T, De Oliveira Brandao, C

Volltext

254P Real-world clinical scenarios during introduction of trastuzumab biosimilar for HER2-positive breast cancer von Wyrwicz, L., Rodríguez Sanchez, C.A., Sanchez-Rovira, P., Lewis, S., Sandschafer, D., San, T.

Volltext

Transcriptomic Profiling of Carboplatin- and Paclitaxel-Resistant Lung Adenocarcinoma Cells Reveals CSF3 as a Potential Biomarker for the Carboplatin Plus Paclitaxel Doublet Regime... von Raungrut, Pritsana, Tanyapattrapong, Suchanan, Masjon, Thipphanet, Maungchanburi, Saowanee, Thongsuksai, Paramee

Volltext

INNOVATIONS AT 200 DESIGN FIRMS von Cassidy, Robert

Volltext